Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/10/2014 | CN101977589B 皮肤病学使用的壳聚糖凝胶、其制备方法及其用途 Dermatological use chitosan gel, their preparation and their use |
12/10/2014 | CN101972234B 莫达非尼分散片及其制备方法 Modafinil tablet and its preparation method |
12/10/2014 | CN101952433B 在疾病的诊断与治疗中的PTHrP,其亚型及其拮抗剂 PTHrP in the diagnosis and treatment of disease, and its subtypes and antagonists |
12/10/2014 | CN101928265B 1-(肉桂酰基)-4-烷基酰胺哌嗪化合物及其制备方法 1- (cinnamoyl) -4- alkylamide piperazine compounds and methods |
12/10/2014 | CN101896464B 青藤碱衍生物和它们的合成方法 Sinomenine derivatives and their synthesis |
12/10/2014 | CN101842490B 抗原组合物及其在核酸的靶向递送中的应用 Antigen composition and its application in the targeted delivery of nucleic acids |
12/10/2014 | CN101827936B Cdh3肽以及含有cdh3肽的药剂 Cdh3 peptides and peptide drug containing cdh3 |
12/10/2014 | CN101815521B 新siRNA结构 New siRNA structure |
12/10/2014 | CN101700382B 癌痛消滴丸 Pain elimination Dripping Pills |
12/10/2014 | CN101679239B 组蛋白脱乙酰酶抑制剂 Histone deacetylase inhibitors |
12/10/2014 | CN101678078B Sparc及其使用方法 Sparc and methods of use |
12/10/2014 | CN101595083B [f-18]-标记的l-谷氨酸、[f-18]-标记的l-谷氨酰胺、它们的衍生物和应用以及制备方法 [F-18] - labeled l- glutamate, [f-18] - labeled l- glutamine, derivatives thereof, and preparation method and application |
12/10/2014 | CN101506168B 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 With a fast rate of penetration of the skin of positively charged water-soluble aryl anthranilic acid prodrug |
12/10/2014 | CN101437823B 多晶型 Polymorph |
12/09/2014 | US8907131 Compounds for treating proliferative disorders |
12/09/2014 | US8907109 Methods and systems for treating cell proliferation disorders with psoralen derivatives |
12/09/2014 | US8907105 1,2,3-triazolium ionic liquids |
12/09/2014 | US8907101 Sulfonamide derivatives |
12/09/2014 | US8907097 Pyrido[4,3-b]indoles containing rigid moieties |
12/09/2014 | US8907096 N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase |
12/09/2014 | US8907095 Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119 |
12/09/2014 | US8907094 Kinase inhibitors |
12/09/2014 | US8907093 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
12/09/2014 | US8907092 Inhibitors of IAP |
12/09/2014 | US8907089 Fused heterocyclic ring derivative and use thereof |
12/09/2014 | US8907086 Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors |
12/09/2014 | US8907075 Compositions and methods for gene silencing |
12/09/2014 | US8907069 Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
12/09/2014 | US8907057 Peptides that target dorsal root ganglion neurons |
12/09/2014 | US8906967 Sesquiterpenes and derivatives thereof for use as feed additives |
12/09/2014 | US8906966 Medicaments containing panthenol |
12/09/2014 | US8906965 Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation |
12/09/2014 | US8906964 Methods of administering compositions comprising docosapentaenoic acid |
12/09/2014 | US8906963 Deodorization of peracids |
12/09/2014 | US8906962 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
12/09/2014 | US8906960 Synergistic effect of tocotrienols and curcumin |
12/09/2014 | US8906959 Vegetable oil composition containing palm mid-fraction fat and method of reducing plasma cholesterol |
12/09/2014 | US8906958 Compounds and mixtures for influencing inflammatory states |
12/09/2014 | US8906957 Polyphenol-rich extract from plant material |
12/09/2014 | US8906956 Composition comprising (−)-Δ9-trans-tetrahydrocannabinol |
12/09/2014 | US8906955 Use of adrenergic beta-3-receptor agonists in anti-aging |
12/09/2014 | US8906954 Selective inhibitors of histone deacetylase |
12/09/2014 | US8906953 Pyrrolidine substitute flavones for the treatment of inflammatory disorders |
12/09/2014 | US8906951 Use of NK-1 receptor antagonists in pruritus |
12/09/2014 | US8906950 Ketorolac tromethamine compositions for treating or preventing ocular pain |
12/09/2014 | US8906949 Orally disintegrating tablets of zolmitriptan and process for preparing the same |
12/09/2014 | US8906948 Choline cocrystal of epalrestat |
12/09/2014 | US8906947 Method for the separation and purification of epothilones |
12/09/2014 | US8906946 TRPM8 receptor antagonists |
12/09/2014 | US8906945 Inhibitors of bacterial type III secretion system |
12/09/2014 | US8906944 Compounds as tyrosine kinase modulators |
12/09/2014 | US8906943 Synthetic compounds and methods to decrease nicotine self-administration |
12/09/2014 | US8906942 Modulators of aldhehyde dehydrogenase activity and methods of use thereof |
12/09/2014 | US8906941 Carboxamide compounds and their use as calpain inhibitors |
12/09/2014 | US8906940 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
12/09/2014 | US8906939 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
12/09/2014 | US8906938 C5aR antagonists |
12/09/2014 | US8906937 Flavivirus inhibitors and methods of their use |
12/09/2014 | US8906936 Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereof |
12/09/2014 | US8906935 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them |
12/09/2014 | US8906934 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors |
12/09/2014 | US8906933 Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists |
12/09/2014 | US8906932 Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4Hquinazolin-3-yl)-piperidine-2,6-dione |
12/09/2014 | US8906931 9-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof |
12/09/2014 | US8906930 Quinazoline derivatives |
12/09/2014 | US8906929 Inhibitors of human immunodeficiency virus replication |
12/09/2014 | US8906926 Substituted diketopiperazine analogs for use as drug delivery agents |
12/09/2014 | US8906925 Pyrido[4,3-B]indoles containing rigid moieties |
12/09/2014 | US8906924 (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors |
12/09/2014 | US8906923 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones |
12/09/2014 | US8906922 Substituted triazoles useful as AXl inhibitors |
12/09/2014 | US8906921 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists |
12/09/2014 | US8906920 N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
12/09/2014 | US8906919 Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers |
12/09/2014 | US8906917 Pyrimidine cyclohexyl glucocorticoid receptor modulators |
12/09/2014 | US8906916 Pyrimidine derivatives as FAK inhibitors |
12/09/2014 | US8906915 Compounds, compositions, and methods for controlling biofilms |
12/09/2014 | US8906914 Ethylene diamine modulators of fatty acid hydrolase |
12/09/2014 | US8906913 Azabicyclohexanes |
12/09/2014 | US8906911 Chemokine receptor antagonists |
12/09/2014 | US8906910 Imidazopyridine derivatives as PI3 kinase |
12/09/2014 | US8906909 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety |
12/09/2014 | US8906908 Hydroxybupropion analogues for treating drug dependence |
12/09/2014 | US8906907 Hypotensive lipid and timolol compositions and methods of using same |
12/09/2014 | US8906906 Viral replication inhibitors |
12/09/2014 | US8906905 Methods of treating disorders associated with protein polymerization |
12/09/2014 | US8906903 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
12/09/2014 | US8906902 Antibacterial compounds |
12/09/2014 | US8906901 Administration of dipeptidyl peptidase inhibitors |
12/09/2014 | US8906900 PRMT5 inhibitors and uses thereof |
12/09/2014 | US8906899 Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
12/09/2014 | US8906898 Solid forms of ceftolozane |
12/09/2014 | US8906897 Antimicrobial agents based on hemin derivatives |
12/09/2014 | US8906896 Platinum acridine anti-cancer compounds and methods thereof |
12/09/2014 | US8906895 Optically active dibenzylamine derivative, and method for preparing thereof |
12/09/2014 | US8906894 Methods for preventing and treating thrombotic disorders |
12/09/2014 | US8906892 4-pregenen-11β-17-21-triol-3,20-dione derivatives |
12/09/2014 | US8906891 Na/K-ATPase ligand |
12/09/2014 | US8906890 Very low-dosed solid oral dosage forms for HRT |
12/09/2014 | US8906889 C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |